17.32
Edgewise Therapeutics Inc (EWTX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
-
|
- | - | - | - |
|
|
7.29%
42.61
|
45.96 | 40.43 | 38.11 | 34.75 |
| Operating Income/Loss |
7.29%
-42.61
|
-45.96 | -40.43 | -38.11 | -34.75 |
| Income/Loss From Continuing Operations Before Tax |
11.48%
-36.12
|
-40.80 | -34.13 | -31.50 | -28.52 |
| Income/Loss From Continuing Operations After Tax |
11.48%
-36.12
|
-40.80 | -34.13 | -31.50 | -28.52 |
|
|
11.48%
-36.12
|
-40.80 | -34.13 | -31.50 | -28.52 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
10.31%
104.94
|
95.13 | 93.81 | 93.52 | 87.57 |
| Diluted Average Shares |
10.31%
104.94
|
95.13 | 93.81 | 93.52 | 87.57 |
| Basic Earnings Per Share |
20.93%
-0.34
|
-0.43 | -0.36 | -0.34 | -0.33 |
| Diluted Earnings Per Share |
20.93%
-0.34
|
-0.43 | -0.36 | -0.34 | -0.33 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):